Incorporating BCNU Wafers into Malignant Glioma Treatment: European Case Studies

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.30, Iss.3, 2010-03, pp. : 195-204

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Oncolytic viruses for the treatment of malignant glioma

By Merrill Melinda K Selznick Lee A Gromeier Matthias

Expert Opinion on Therapeutic Patents, Vol. 16, Iss. 3, 2006-03 ,pp. : 363-371

Informa Healthcare

Access to resources Recommend Favorite

Cilengitide, an integrin antagonist, has shown potential in the treatment of malignant glioma

Inpharma, Vol. 1, Iss. 1589, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite

Emerging drugs for malignant glioma

By Mason Warren P

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 81-94

Informa Healthcare

Access to resources Recommend Favorite

Cell line studies of glioblastoma and malignant glioma using a newly discovered prenylated chalcone

By Teng Chih-Chuan Sze Chun-I Wang Ting-Chung Lien Ching-Yi Liao Wayne C.

Pharmaceutical Biology (Formerly International Journal of Pharmacognosy), Vol. 49, Iss. 3, 2011-03 ,pp. : 314-318

Informa Healthcare

Access to resources Recommend Favorite

Drug or Vaccine?: Selecting the Appropriate Treatment for Malignant Glioma Patients

By Dai Xue-jun

Drugs, Vol. 70, Iss. 12, 2010-08 ,pp. : 1477-1486

Adis International

Access to resources Recommend Favorite